Acadia Healthcare Company, Inc. $ACHC Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Key Points

• UBS Asset Management reduced its Acadia Healthcare stake by 19.2% in the second quarter, selling 52,869 shares and retaining 222,444 shares valued at approximately $6.6 million.
• Institutional interest was mixed, with BlackRock and Jefferies initiating positions while Wellington and Goldman Sachs significantly increased their holdings.
• Acadia reported quarterly EPS of $0.38, beating estimates of $0.35, and revenue of $865.84 million; analysts maintain a consensus “Hold” rating with an average price target of $29.85.

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 19.2% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 222,444 shares of the company's stock after selling 52,869 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.24% of Acadia Healthcare worth $6,569,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in ACHC. BlackRock Inc. purchased a new stake in shares of Acadia Healthcare in the second quarter valued at about $441,685,000. Wellington Management Group LLP increased its stake in shares of Acadia Healthcare by 24.9% during the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company's stock worth $167,077,000 after purchasing an additional 2,350,760 shares in the last quarter. Goldman Sachs Group Inc. raised its position in shares of Acadia Healthcare by 417.8% during the 4th quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company's stock worth $67,099,000 after purchasing an additional 3,815,471 shares during the last quarter. UBS Group AG lifted its stake in Acadia Healthcare by 8.8% in the 3rd quarter. UBS Group AG now owns 4,336,698 shares of the company's stock valued at $107,377,000 after buying an additional 350,484 shares in the last quarter. Finally, Jefferies Financial Group Inc. acquired a new stake in Acadia Healthcare during the 2nd quarter valued at $106,458,000.

Acadia Healthcare Price Performance

ACHC stock opened at $27.50 on Wednesday. The stock has a market capitalization of $2.56 billion, a price-to-earnings ratio of -2.21, a price-to-earnings-growth ratio of 9.06 and a beta of 0.62. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. Acadia Healthcare Company, Inc. has a 52-week low of $11.43 and a 52-week high of $35.83. The stock's fifty day simple moving average is $30.67 and its 200-day simple moving average is $26.74.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.03. The firm had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The firm's revenue for the quarter was down .4% compared to the same quarter last year. During the same period in the prior year, the business posted $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Equities research analysts expect that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Guggenheim boosted their price target on Acadia Healthcare from $38.00 to $39.00 and gave the stock a "buy" rating in a report on Thursday, July 30th. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Acadia Healthcare in a research note on Friday, June 12th. KeyCorp boosted their target price on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an "overweight" rating in a research note on Tuesday, July 14th. Barclays upped their target price on shares of Acadia Healthcare from $25.00 to $32.00 and gave the company an "equal weight" rating in a report on Thursday, July 30th. Finally, Cantor Fitzgerald reiterated a "neutral" rating on shares of Acadia Healthcare in a report on Wednesday, July 29th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $29.85.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.